INVO BioScience Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2015
2016
2017
2018
Sales/Revenue
11.70
50.90
282.10
494.40
Cost of Goods Sold (COGS) incl. D&A
7.80
15.10
52.00
90.40
Gross Income
3.90
35.80
230.20
404
SG&A Expense
599.00
2,146.20
870.60
3,038.10
EBIT
595.10
2,110.40
640.40
2,634.10
Unusual Expense
4,332.20
-
40.90
-
Interest Expense
32.00
13.80
20.90
442
Pretax Income
4,959.20
2,124.30
702.20
3,076.10
Consolidated Net Income
4,959.20
2,124.30
702.20
3,076.10
Net Income
4,959.20
2,124.30
702.20
3,076.10
Net Income After Extraordinaries
4,959.20
2,124.30
702.20
3,076.10
Net Income Available to Common
4,959.20
2,124.30
702.20
3,076.10
EPS (Basic)
0.04
0.02
0.00
0.02
Basic Shares Outstanding
128,567.60
139,186.60
141,305.10
147,333.10
EPS (Diluted)
0.04
0.02
0.00
0.02
Diluted Shares Outstanding
128,567.60
139,186.60
141,305.10
147,333.10
EBITDA
589.40
2,108.50
637.60
2,628.90
About INVO BioScience
View Profile
